Pharmacotherapy of the acute alcohol withdrawal syndrome.
D000437:Alcoholism / Q000628:therapy*; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002697:Chloral Hydrate / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006919:Hydroxyzine / Q000627:therapeutic use; D007022:Hypotension / Q000139:chemically induced; D010242:Paraldehyde / Q000627:therapeutic use; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D014151:Anti-Anxiety Agents; D001463:Barbiturates; D010640:Phenothiazines; D006919:Hydroxyzine; D002697:Chloral Hydrate; D002707:Chlordiazepoxide; D006220:Haloperidol; D003975:Diazepam; D010242:Paraldehyde